FOLFIRI + E7820
Phase 1/2Terminated 0 watching 0 views this week⚡ Active
41
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colon Cancer
Conditions
Colon Cancer, Rectal Cancer
Trial Timeline
Sep 30, 2011 → Jun 22, 2015
NCT ID
NCT01347645About FOLFIRI + E7820
FOLFIRI + E7820 is a phase 1/2 stage product being developed by Eisai for Colon Cancer. The current trial status is terminated. This product is registered under clinical trial identifier NCT01347645. Target conditions include Colon Cancer, Rectal Cancer.
Hype Score Breakdown
Clinical
13
Activity
8
Company
10
Novelty
4
Community
3
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01347645 | Phase 1/2 | Terminated |
Competing Products
20 competing products in Colon Cancer